Accelerated & Efficient Drug Development

Minerva Imaging is a scientifically driven CRO founded in 2011.
Our focus is on the use of advanced oncology models and molecular imaging for translational cancer research and drug development.

Our services

Oncology

We have extensive experience in design and execution of pre-clinical studies for drug development within oncology.

Read more

Radionuclide Therapy

We have substantial experience in performing studies with targeted radionuclide therapy in oncology.

Read more

Molecular Imaging

Building on more than two decades of research in Nuclear Medicine we are proficient in conducting molecular imaging.

Read more

Cardiovascular Disease

We have in-depth knowledge in cardiovascular disease and advanced imaging to study drug interventions.

Read more

We engage with our clients to understand their scientific questions and discuss how our methods and capabilities can provide answers.

Optimal results require attention to details

We engage with our clients to understand their scientific questions and discuss how our methods and capabilities can provide answers. Our competences build on more than two decades of research within oncology and molecular imaging performed at the University of Copenhagen and Rigshospitalet, the National University Hospital of Denmark.

Read about us

Latest news

September 19th 2019

ESMO Congress, 2019

Minerva Imaging will be present at the ESMO Congress, September 27-October 1, 2019 in Barcelona, Spain

Read story
August 26th 2019

WMIC Congress, 2019

Minerva Imaging will be present at the WMIC Congress, September 4-7 2019 in Montreal, Canada

Read story
June 21st 2019

SNMMI 2019 Annual Meeting

Minerva Imaging will attend the SNMMI 2019 Annual Meeting, June 22-25.

Read story
June 3rd 2019

Targeted Radiopharmaceutical Summit, 2019

Minerva Imaging are proud to sponsor this years summit.

Read story